Login
$SYRE
$99.05 +$0.00 (0.0%) After hours

$SYRE 3 SEC Filings

Filed On Filing
01 Oct 2024 Form 3: Sloan Sheldon, Chief Medical Officer

No securities owned

16 May 2024 Form 3: Milligan Sandra, Director

No securities owned

05 Feb 2024 Form 3: McKenna Mark C., Director
27 Nov 2023 Form 3: Albers Jeffrey W., Director

No securities owned

27 Nov 2023 Form 3: Stelzer Laurie, Director

No securities owned

05 Sep 2023 Form 3: King-Jones Heidy, See Remarks

No securities owned

05 Sep 2023 Form 3: Burrows Scott L, Chief Financial Officer

No securities owned

30 Jun 2023 Form 3: Fairmount Funds Management Llc, Director and 5 others

Holds 276,082 shares of Common Stock

30 Jun 2023 Form 3: Turtle Cameron, Chief Operating Officer

Holds 576,699 shares of Common Stock

30 Jun 2023 Form 3: Henderson Michael Thomas, Director
27 Jan 2023 Form 3: Neuman Linda L, Chief Medical Officer

Holds 4,000 shares of Common Stock

01 Dec 2022 Form 3: Goldberg Jeff Marc, Director

No securities owned

25 Aug 2022 Form 3: Kastenmayer James Paul, Interim CEO & General Counsel

Holds 4,000 shares of Common Stock

16 Nov 2021 Form 3: Smith Hunter C, Director

No securities owned

08 Jul 2021 Form 3: Alspaugh Jonathan, Chief Financial Officer

No securities owned

22 Jun 2021 Form 3: Souza Marcio, Director

No securities owned

25 Feb 2021 Form 3: Baker Bros. Advisors Lp, Director and 5 others

Holds 315,516 shares of Common Stock

25 Feb 2021 Form 3: Brownstein Sara, Director

No securities owned

08 Feb 2021 Form 3: Weber Steven, VP, Controller&Princ Acctg Off

Holds 17,652 shares of Common Stock

17 Dec 2020 Form 3: Lawton Alison Frances, Director

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support